BNP Paribas Financial Markets’s IGM Biosciences IGMS Stock Holding History

BNP Paribas Financial Markets’s Portfolio IGMS Stock Details IGMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-3,133	Closed	-$3.51K	–	5659
2025 Q2	$3.51K	Sell	3,133 -9	-0.3%	-$11	﹤0.01%	4996
2025 Q1	$3.61K	Sell	3,142 -3,492	-53%	-$6.49K	﹤0.01%	4904
2024 Q4	$40.5K	Buy	+6,634	New	+$78.8K	﹤0.01%	4510
2022 Q4	–	Sell	-11,645	Closed	-$265K	–	4302
2022 Q3	$265K	Buy	+11,645	New	+$235K	﹤0.01%	3361

Other funds holding IGMS

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

BNP Paribas Financial Markets's IGMS Position: Q3 2025 in Review

BNP Paribas Financial Markets sold out of IGM Biosciences (IGMS) in Q3 2025, closing a stake of 3,133 shares — an estimated $3.51K sold.

BNP Paribas Financial Markets first reported a position in IGMS in Q3 2022 and held it in 4 quarters. The position peaked at $265K in Q3 2022. 1 fund tracked by Wall St. Rank holds IGMS as of Q3 2025.

BNP Paribas Financial Markets reported no remaining IGM Biosciences position as of Q3 2025 after selling out during the quarter.
BNP Paribas Financial Markets sold 3,133 IGM Biosciences shares in Q3 2025, an estimated $3.51K.
BNP Paribas Financial Markets first reported a position in IGM Biosciences in Q3 2022 and held it in 4 quarters.
BNP Paribas Financial Markets's IGM Biosciences position peaked at $265K in Q3 2022.
1 fund tracked by Wall St. Rank held IGM Biosciences as of Q3 2025.

Based on BNP Paribas Financial Markets's 13F filing for Q3 2025, filed 13 Nov 2025.